New study and database on biomarkers - a major aid in Alzheimer’s research
In a new study published in Lancet Neurology, researchers at Sahlgrenska Academy have been able to show which blood and cerebrospinal fluid biomarkers that best differentiate between patients with Alzheimer’s disease and controls. Parallel to the study, the researchers developed a large database that gathers data on biomarkers in Alzheimer’s and other forms of dementia.Alzheimer’s disease is the most common form of dementia. It causes enormous suffering in both the patients and relatives, and the disease costs society more than all cardiovascular and cancer healthcare combined. An